newsfilter
← Latest News
Business Wire·

VFMCRP receives positive CHMP opinion for Tavneos® for the treatment of ANCA-associated vasculitis

Committee for Medicinal Products for Human Use (CHMP) recommends approval of first orally administered therapy for the treatment of ANCA-associated vasculitis (GPA and MPA) in Europe European Commission decision for EU Marketing Authorization expe